ÂÜÀòÂÒÂ×

Doug Hodges has a strong background in biologics drug research and development, with experience in leading research activities, managing development candidates, and overseeing the advancement of therapeutic targets. Doug has successfully supported various programs in clinical development, established partnerships, and provided strategic direction in the biotech industry. Doug's expertise in immunomodulatory receptors and therapeutic proteins has been instrumental in their roles as Associate Director, Senior Principal Scientist, and Senior Scientist in companies such as Tizona Therapeutics, Merck Research Laboratories, and Genencor. With a degree in Genetics from the University of California, Davis, Doug continues to make significant contributions to the field of biotechnology.